Waltham, Massachusetts, United States, January 2025 – Roxanne McGrath has joined Sionna Therapeutics as the Vice President, Talent, bringing her extensive experience in talent management, organizational development, and strategic human resources to this innovative biopharmaceutical company. Roxanne will play a pivotal role in driving Sionna’s mission to revolutionize treatment for cystic fibrosis (CF) through novel therapies that restore CFTR function.
Roxanne joins Sionna Therapeutics after a successful tenure at GSK, where she served as Senior Director, HRBP – Vaccines Global Technical R&D. During her 2.5 years with GSK, she led HR strategies across a 1,000-person global organization and supported a business transformation in Cambridge, Massachusetts, following GSK’s acquisition of Affinivax. Roxanne also served as Interim Chief People Officer/HR Integration Lead, overseeing the integration process and building talent acquisition strategies.
Prior to GSK, Roxanne held leadership roles at Cell Signaling Technology (CST), where she served as Director of Global Talent Acquisition and successfully scaled global talent efforts to support the company’s rapid growth in the life sciences sector. Her career also includes significant contributions at companies like Microsoft, Black Duck Software, and Groove Networks, where she built and led HR functions, contributing to company growth and successful acquisitions.
Roxanne is also the founder of McGrath Wellness, a holistic health practice dedicated to empowering clients to take control of their well-being.
About Sionna Therapeutics
Sionna Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for cystic fibrosis. With a focus on stabilizing CFTR’s nucleotide-binding domain 1 (NBD1), Sionna is advancing novel small molecules to address the root cause of CF and improve clinical outcomes. Drawing on over a decade of extensive research, the company is building a pipeline of differentiated medicines designed to restore CFTR function and improve the quality of life for people with CF.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
